Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Sector
Healthcare
Region
US
AUM
7.61B
Fund Score
SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) Quotes, Forecast and News Summary
SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI) stock price, news, charts, stock research, profile.
| Open | $97.63 |
| High | $99.01 |
| 52 Wk High | $105.47 |
| AUM | 7.61B |
| Dividend | $0.26 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 5.1M |
| Market Cap | $14.42B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 15.69 |
| Prev. Close | $96.24 |
| Low | $97.53 |
| 52 Wk Low | $71.99 |
| Shares Out | 75.22M |
| Yield | 0.27% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 8.45M |
| Beta | 0.95 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | 4.05 |
Recent News
FAQ
Q
How do I buy SPDR Series Trust SPDR S&P Biotech ETF (XBI) stock?
A
You can purchase shares of SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.
Q
Who are SPDR Series Trust SPDR S&P Biotech ETF (XBI) competitors?
A
There are no as such competitors for SPDR Series Trust SPDR S&P Biotech ETF.
Q
What is the forecast, or price target, for SPDR Series Trust SPDR S&P Biotech ETF (XBI) stock?
A
There is no analysis for SPDR Series Trust SPDR S&P Biotech ETF to provide a consensus price target.
Q
What is the current price for SPDR Series Trust SPDR S&P Biotech ETF (XBI)?
A
The stock price for SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI) is $98.82 last updated November 25, 2024 at 10:40 AM EST.
Q
Does SPDR Series Trust SPDR S&P Biotech ETF (XBI) pay a dividend?
A
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on September 26, 2018 to stockholders of record on September 21, 2018.
Q
When is SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) reporting earnings?
A
SPDR Series Trust SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.
Q
Is SPDR Series Trust SPDR S&P Biotech ETF (XBI) going to split?
A
There is no upcoming split for SPDR Series Trust SPDR S&P Biotech ETF.
| Open | $97.63 |
| High | $99.01 |
| 52 Wk High | $105.47 |
| AUM | 7.61B |
| Dividend | $0.26 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 5.1M |
| Market Cap | $14.42B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 15.69 |
| Prev. Close | $96.24 |
| Low | $97.53 |
| 52 Wk Low | $71.99 |
| Shares Out | 75.22M |
| Yield | 0.27% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 8.45M |
| Beta | 0.95 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | 4.05 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Jan 31, 2006 |
| Managers | Raymond Donofrio Karl A. Schneider |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved